Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in CashChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowNet Cash FlowNet IncomeShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Werewolf Therapeutics (HOWL) Change in Receivables (2022 - 2024)

Werewolf Therapeutics (HOWL) has disclosed Change in Receivables for 3 consecutive years, with -$464000.0 as the latest value for Q4 2024.

  • Quarterly Change in Receivables rose 89.83% to -$464000.0 in Q4 2024 from the year-ago period, while the trailing twelve-month figure was -$464000.0 through Sep 2025, up 91.48% year-over-year, with the annual reading at -$1.3 million for FY2024, 75.8% up from the prior year.
  • Change in Receivables for Q4 2024 was -$464000.0 at Werewolf Therapeutics, down from -$81000.0 in the prior quarter.
  • The five-year high for Change in Receivables was $2.6 million in Q4 2022, with the low at -$4.6 million in Q4 2023.
  • Average Change in Receivables over 3 years is $0.0, with a median of -$230000.0 recorded in 2024.
  • The sharpest move saw Change in Receivables crashed 273.55% in 2023, then surged 92.03% in 2024.
  • Over 3 years, Change in Receivables stood at $2.6 million in 2022, then plummeted by 273.55% to -$4.6 million in 2023, then surged by 89.83% to -$464000.0 in 2024.
  • According to Business Quant data, Change in Receivables over the past three periods came in at -$464000.0, -$81000.0, and -$230000.0 for Q4 2024, Q3 2024, and Q2 2024 respectively.